United HealthCare to Cover Genomic Health’s Oncotype Dx Breast Cancer Test | GenomeWeb
NEW YORK (GenomeWeb News) — Genomic Health today said that United HealthCare Insurance will cover its Oncotype Dx test for women who have early-stage breast cancer.  
The Oncotype DX analyzes the risk of a recurrence of breast cancer and predicts the chances that chemotherapy will be beneficial. Genomics Health said the test will be covered for claims for services after Jan. 3.
In March 2006 the National Heritage Insurance Company, a Medicare contractor, said it would cover the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.